Suppr超能文献

鉴定与三阴性乳腺癌相关的基因枢纽和大麻二酚类似物潜在抑制剂:一项计算机研究。

Identification of Genes Hub Associated with Triple-Negative Breast Cancer and Cannabidiol Analogs Potential Inhibitory Agents: An In-silico Study.

机构信息

GINUMED, Rafael Núñez University Corporation, Cartagena D.T. y C. Colombia.

Pharmacology and Therapeutic group, University of Cartagena, Cartagena D.T. y C. Colombia.

出版信息

Asian Pac J Cancer Prev. 2024 May 1;25(5):1649-1661. doi: 10.31557/APJCP.2024.25.5.1649.

Abstract

OBJECTIVE

Triple-negative breast cancer presents a significant challenge in oncology due to its complex treatment and aggressive nature. This subtype lacks common cancer cell receptors like estrogen, progesterone, and human epidermal growth factor receptor 2 receptors. This study aimed to identify, through bioinformatic analysis, the key genes associated with triple-negative breast cancer. In addition, CBD analogs with potential inhibitory effects on these genes were evaluated through docking and molecular dynamics.

METHODS

Gene expression profiles from the GSE178748 dataset were analyzed, focusing on MDA-MB-231 breast cancer cell lines. Differentially expressed genes were determined through protein-protein interaction networks and subsequently validated. Additionally, the inhibitory effects of cannabidiol analogs on these hub genes were assessed using molecular docking and dynamics.

RESULTS

Analysis of the hub highlighted RPL7A, NHP2L1, and PSMD11 as significant players in TNBC regulation. Ligand 44409296 showed the best affinity energy with RPL7A, while 166505341 exhibited the highest affinity with NHP2L1 and PSMD11, surpassing CBD. Analyses of RMSD, RMSF, SASA, and Gyration Radius indicated structural stability and interactions of the proteins with ligands over time. MMGBSA calculations showed favorable binding energies for the ligands with the target proteins.

CONCLUSION

In conclusion, this study identified key genes, namely RPL7A, NHP2L1, and PSMD11, associated with triple-negative breast cancer and demonstrated promising interactions with cannabidiol analogs, particularly 44409296 and 166505341. These findings suggest potential therapeutic targets and highlight the relevance of further clinical investigations. Additionally, the ligands exhibited favorable ADME properties and low toxicity, underscoring their potential in future drug development for TNBC treatment.

摘要

目的

三阴性乳腺癌因其复杂的治疗和侵袭性而在肿瘤学领域构成重大挑战。这种亚型缺乏常见的癌细胞受体,如雌激素、孕激素和人表皮生长因子受体 2 受体。本研究旨在通过生物信息学分析,确定与三阴性乳腺癌相关的关键基因。此外,还通过对接和分子动力学评估了对这些基因具有潜在抑制作用的 CBD 类似物。

方法

从 GSE178748 数据集分析基因表达谱,重点关注 MDA-MB-231 乳腺癌细胞系。通过蛋白质-蛋白质相互作用网络确定差异表达基因,并进行后续验证。此外,还使用分子对接和动力学评估了大麻二酚类似物对这些枢纽基因的抑制作用。

结果

对枢纽基因的分析突出了 RPL7A、NHP2L1 和 PSMD11 作为 TNBC 调节的重要参与者。配体 44409296 与 RPL7A 具有最佳亲和力能,而 166505341 与 NHP2L1 和 PSMD11 具有最高亲和力,超过了 CBD。对 RMSD、RMSF、SASA 和回转半径的分析表明,随着时间的推移,蛋白质与配体的结构稳定性和相互作用。MMGBSA 计算表明,配体与靶蛋白具有有利的结合能。

结论

总之,本研究确定了与三阴性乳腺癌相关的关键基因,即 RPL7A、NHP2L1 和 PSMD11,并证明了它们与大麻二酚类似物具有有前途的相互作用,特别是 44409296 和 166505341。这些发现表明了潜在的治疗靶点,并强调了进一步临床研究的相关性。此外,这些配体表现出有利的 ADME 特性和低毒性,突出了它们在未来三阴性乳腺癌治疗药物开发中的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d702/11318821/2759f34e908d/APJCP-25-1649-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验